Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

NCT04781140 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

DRUG: 100mg SPN-812
DRUG: Placebo

Sponsor

Supernus Pharmaceuticals, Inc.